ArticleDiagnostics (Basel, Switzerland)2020
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients.
Aneta Cymbaluk-Płoska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it